Artificial Intelligence

Artificial intelligence, or AI, is an umbrella term for machine learning and deep learning. It is where a machine takes in information from its surroundings and, from that, makes the most optimal decision appropriate to the situation.

How Artificial Intelligence Is Revolutionizing Emergency Medicine

From triage algorithms to digital twins, artificial intelligence is reshaping emergency care, delivering faster decisions, smarter workflows, and raising vital questions about trust, transparency, and regulation.

Artificial Intelligence in Histopathology

Uncovering the Mystery of the Human Brain with Computational Neuroscience

Artificial Intelligence in Cardiology

Can Artificial Intelligence be used to Diagnose Brain Aneurysms?

The Role of AI in Pathogen Detection and Epidemic Prediction

Applying Deep Learning to Localization Microscopy

Managing the Explosion of Healthcare Data to Harness its Power

AI Psychosis: How Artificial Intelligence May Trigger Delusions and Paranoia

Deep-Learning in Radiology

Is Data at the Center of Healthcare for the Future?

Artificial Intelligence in CBT

See more featured articles »

Machine Learning in Drug Development

Artificial Intelligence and Deep Learning in Medicine

The Medical Industries That Are Most Likely to Be Impacted by Ai

Recent Developments in Health Technology

Ethical Considerations in AI-Driven Healthcare

Artificial Intelligence and Life Science

Beyond Virtual Consultations: The Rise of AI-Driven Virtual Healthcare Assistants

AI-Powered Genomic Analysis: Revolutionizing the Detection of Genetic Mutations

The Pros and Cons of Healthcare Chatbots

What does ChatGPT mean for Healthcare?

Latest Artificial Intelligence News and Research

AI uncovers evolution of genetic control elements in mammalian cerebellum

Artificial intelligence allows tracing the evolution of genetic control elements in the developing mammalian cerebellum.

30 Jan 2026

AI-driven model enhances treatment decisions for cancer patients after heart attack

Cancer patients who suffer a heart attack face a dangerous mix of risks, which makes their clinical treatment particularly challenging.

30 Jan 2026

AI-supported mammography improves early detection of breast cancer

Artificial intelligence (AI)-supported mammography identifies more cancers during screening and reduces the rate of breast cancer diagnosis by 12% in the years following, finds the first randomised controlled trial of its kind involving over 100,000 Swedish women published in The Lancet journal.

30 Jan 2026

Turning everyday eggs into powerful nutrient delivery systems

Eggs as functional foods: this review explores enrichment techniques that enhance nutrient bioavailability and support health through precision nutrition.

30 Jan 2026

FIU establishes hub for cardiovascular innovation

With cardiovascular disease remaining the leading cause of death in the United States, this Heart Month (February), FIU is establishing an interdisciplinary center designed to accelerate breakthroughs in heart disease research, education, and innovation.

30 Jan 2026

Biomarker discovery may pave the way for early diagnosis of Parkinson's

A team led by researchers at Chalmers University of Technology, Sweden, has succeeded in identifying biomarkers for Parkinson's disease in its earliest stages, before extensive brain damage has occurred.

29 Jan 2026

Smartwatch app to track social interactions of stroke survivors may help maximize recovery

A smartwatch app designed to measure social interactions of hospitalized stroke survivors may enable new treatments to preserve or enhance cognition, social engagement and quality of life after a stroke, according to a preliminary study to be presented at the American Stroke Association's International Stroke Conference 2026.

29 Jan 2026

Umbilical cord blood markers may predict future type 1 diabetes

One day, there could be a new test to screen for type 1 diabetes, now that scientists have found markers in the blood of the umbilical cords of children who were later diagnosed with the disease.

29 Jan 2026

AI model accurately predicts need for skilled nursing after hospital discharge

An artificial intelligence (AI) tool accurately predicted which patients would need a skilled nursing facility after leaving the hospital, a new study shows.

28 Jan 2026

Insilico Medicine and Qilu Pharmaceutical partner to develop AI-designed cardiometabolic drugs

Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern pharmaceutical enterprise in China, as well as its subsidiary Shanghai Qilu Pharmaceutical Research Center, today announced a strategic partnership on innovative drug development, leveraging Insilico's proprietary Pharma.AI platform to jointly develop small molecule inhibitors, focusing on specific targets for cardiometabolic disease management.

27 Jan 2026

UVA Data Science researcher leads $4.7M project for AI-powered diabetes management

University of Virginia School of Data Science researcher Heman Shakeri has been awarded a major new research grant to lead work at the intersection of machine learning and diabetes care.

27 Jan 2026

Multi-fluid microRNA signals as markers of endometriosis

Researchers uncover distinct microRNA profiles in bodily fluids, offering insights into noninvasive diagnostic markers for endometriosis and its complexities.

27 Jan 2026

Doctors increasingly see AI scribes in a positive light. But hiccups persist.

When Jeannine Urban went in for a checkup in November, she had her doctor's full attention.

27 Jan 2026

Wildfire smoke significantly raises stroke risk among older adults

People exposed to wildfire smoke have a higher risk of suffering a stroke, according to research published in the European Heart Journal today (Tuesday).

27 Jan 2026

New prognostic model improves survival prediction for spinal metastasis patients

Spinal metastasis, the spread of cancer to the spine, is a frequent complication in advanced cancer. It often causes severe pain and paralysis, significantly impacting quality of life.

27 Jan 2026

Diagnostic prognostic and therapeutic relevance of PIVKA-II in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, particularly in regions with high hepatitis B virus prevalence.

24 Jan 2026

Three dimensional dataset transforms emergency medical training and robotic assistance

Researchers from Tianjin University have introduced the Emergency Medical Procedures 3D Dataset (EMP3D), a pioneering resource that captures the intricate movements of medical professionals during life-saving interventions with unprecedented precision.

24 Jan 2026

Orphan noncoding RNAs define cancer identity and enable blood-based monitoring

We knew we had something interesting with T3p, a single small RNA found in breast cancer but absent from normal tissue.

24 Jan 2026

Blood-based epigenetic signatures enable early risk assessment in prediabetes

Prediabetes is an extremely heterogeneous metabolic disorder. Scientists from several partner institutes of the German Center for Diabetes Research (DZD) have now used artificial intelligence (AI) to identify epigenetic markers that indicate an elevated risk of complications.

24 Jan 2026

AI-designed NLRP3 inhibitor receives FDA clearance for Parkinson disease trials

Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), today announced that ISM8969, an orally available NLRP3 inhibitor targeting inflammation and neurodegenerative disorders, has recently received investigational new drug (IND) clearance from the U.S. Food and Drug Administration (FDA), intended for the treatment of Parkinson's Disease.

23 Jan 2026